Gov. Gavin Newsom in 2020 signed a law allowing California to manufacture its own insulin, an effort to bring down the cost ...
Like many cancer patients, Michael Wolff wanted answers. But, like many cancer patients in 2015, he wasn't getting them.
The Big 3 companies acting as intermediaries between drugmakers and insurance providers made billions by needlessly jacking ...
The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...
The OIG report points to gaps in documentation and decision-making transparency, particularly in the case of Aduhelm, where FDA records indicated only 13 meetings with Biogen, but congressional ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
A sweeping 2022 law, touted by President Joe Biden as a way to revive U.S. semiconductor manufacturing and reduce reliance on ...
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The new Agenda calls on countries to begin efforts to achieve 17 Sustainable Development Goals (SDGs) over the next 15 years. “The seventeen Sustainable Development Goals are our shared vision ...